Volume 4,Issue 5
Research Progress on the Correlation between Pseudogout and Periprosthetic Infection after Knee Joint Replacement Surgery
†These authors contributed equally to this work and shared first authorship.
Knee osteoarthritis (KOA) is one of the most common degenerative joint diseases in the elderly, and knee arthroplasty is an important treatment for end-stage KOA, which can effectively improve knee pain and function. However, postoperative joint swelling and pain are common clinical complications. Pseudogout caused by calcium pyrophosphate deposition and periprosthetic infection are the most confusing causes. The core strategies of the two treatments are completely different, and differential diagnosis is the core difficulty in clinical practice. The purpose of this paper is to systematically review the metabolic background and triggering factors, clinical characteristics, and key points of identification of periprosthetic infection in pseudogout after knee arthroplasty, so as to provide a reference for clinical optimization of the differential diagnosis process and reduction of misdiagnosis.
[1] Liu A, Ma X, Cui Z, et al., 2021, Unicompartmental Versus Total Knee Arthroplasty for Knee Osteoarthritis: A Meta-Analysis. Orthopedic Journal of China, 29(21): 1955–1960.
[2] Huang M, Chen J, Chen S, et al., 2022, Research Progress on Exercise Therapy for Knee Osteoarthritis. Chinese Journal of Sports Medicine, 41(4): 320–329.
[3] Zhao X, Zhang Y, Li Y, 2021, Research Progress on Stepwise Treatment of Knee Osteoarthritis. Modern Journal of Integrated Traditional Chinese and Western Medicine, 30(30): 3410–3415.
[4] Al-Jabri T, Ridha M, Wood MJ, et al., 2024, An Overview of the Current Diagnostic Approach to Periprosthetic Joint Infections. Orthop Rev (Pavia), 16: 120308.
[5] Rosenthal AK, Ryan LM, 2016, Calcium Pyrophosphate Deposition Disease. N Engl J Med, 374(26): 2575–2584.
[6] Wei M, Zhang H, Sun Y, et al., 2022, Application Value of Musculoskeletal Ultrasound in the Differential Diagnosis of Calcium Pyrophosphate Deposition Disease and Gouty Arthritis. Journal of Clinical Ultrasound in Medicine, 24(12): 885–889.
[7] Sirotti S, Scanu A, Pascart T, et al., 2024, Calcium Pyrophosphate Crystal Formation and Deposition: Where Do We Stand and What Does the Future Hold? Curr Rheumatol Rep, 26(10): 354–365.
[8] Yahia SA, Zeller V, Desplaces N, et al., 2016, Crystal-Induced Arthritis After Arthroplasty: 7 Cases. Joint Bone Spine, 83(5): 559–562.
[9] Matsubara H, Kobata H, Kenzaka T, 2026, Acute Calcium Pyrophosphate Crystal Arthritis Occurring Many Years After Total Knee Arthroplasty: A Case Report. Cureus, 18(2): e104367.
[10] George MP, Ernste FC, Tande A, et al., 2019, Clinical Presentation, Management, and Prognosis of Pseudogout in Joint Arthroplasty: A Retrospective Cohort Study. J Bone Jt Infect, 4(1): 20–26.
[11] Mashayekhi Y, Asgari AM, Pahlevan-Fallahy MT, et al., 2025, The Association Between Crystallopathy and Postoperative Complications Following Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis. Ann Med Surg (Lond), 88(2): 1754–1764.
[12] Ivory D, Velázquez CR, 2012, The Forgotten Crystal Arthritis: Calcium Pyrophosphate Deposition. Mo Med, 109(1): 64–68.
[13] Abhishek A, Tedeschi SK, Pascart T, et al., 2023, The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis Rheumatol, 75(10): 1703–713.
[14] Xie C, Yang C, 2018, Research Progress on the Correlation Between Cartilage Calcium Pyrophosphate Deposition and Ca²⁺/Mg²⁺ Imbalance. Chinese Journal of Sports Medicine, 37(10): 891–894.
[15] Silva BC, Cusano NE, Bilezikian JP, 2024, Primary Hyperparathyroidism. Best Pract Res Clin Endocrinol Metab, 38(1): 101247.
[16] Tonon CR, Silva TAAL, Pereira FWL, et al., 2022, A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia. Med Sci Monit, 28: e935821.
[17] Chinese Society of Osteoporosis and Bone Mineral Research, Chinese Medical Association, 2025, Consensus on the Clinical Application of Vitamin D and Its Analogues (2025 Version). Chinese Journal of Osteoporosis and Bone Mineral Research, 18(5): 497–517.
[18] Baudart P, Molin A, Cesini J, et al., 2017, Calcium Pyrophosphate Deposition Disease Revealing a Hypersensitivity to Vitamin D. Joint Bone Spine, 84(3): 349–351.
[19] Zhang T, Ma M, Jiang M, 2025, Research Progress in the Treatment of Infantile Hypercalcemia Type 1 Caused by CYP24A1 Variants. Journal of Clinical Pediatrics, 43(11): 872–877.
[20] Gandhi A, Mortensen M, Sunny S, et al., 2021, Immobilization-Induced Hypercalcemia in a Patient with Renal Failure. Endocrinol Diabetes Metab Case Rep, 2021: 21–0086.
[21] Bradley AT, King CA, Lin Y, et al., 2022, Distinguishing Periprosthetic Crystalline Arthropathy from Infection in Total Knee Arthroplasty: A Systematic Review. J Knee Surg, 35(6): 668–675.
[22] Mian HM, Lyons JG, Perrin J, et al., 2022, A Review of Current Practices in Periprosthetic Joint Infection Debridement and Revision Arthroplasty. Arthroplasty, 4(1): 31.
[23] Yilmaz MK, Abbaszadeh A, Tarabichi S, et al., 2023, Diagnosis of Periprosthetic Joint Infection: The Utility of Biomarkers in 2023. Antibiotics (Basel), 12(6): 1054.
[24] Altsitzioglou P, Avgerinos K, Karampikas V, et al., 2024, Point of Care Testing for the Diagnosis of Periprosthetic Joint Infections: A Review. SICOT J, 10: 24.
[25] Cole M, Patel A, Collins L, et al., 2023, Pseudogout After Total Knee Arthroplasty Meeting Minor Criteria for Infection Treated by Polyethylene Exchange. Orthop Rev (Pavia), 15: 67912.
[26] Iwasaki K, Nakamura T, Shin S, et al., 2019, Calcium Pyrophosphate Deposition Disease After Total Knee Arthroplasty: Comparison with Periprosthetic Joint Infection. J Orthop, 16(2): 128–132.
[27] Falkowski AL, Jacobson JA, Kalia V, et al., 2020, Cartilage Icing and Chondrocalcinosis on Knee Radiographs in the Differentiation Between Gout and Calcium Pyrophosphate Deposition. PLoS One, 15(4): e0231508.
[28] Wu X, Tang B, Zhou G, et al., 2023, MRI Manifestations and Diagnostic Value of Infection After Artificial Joint Replacement. Chinese Journal of Gerontology, 43(12): 2896–2899.
[29] Xu W, Xu J, Wang Y, et al., 2025, Clinical Significance of Spectral CT Post-Processing Technology in Differentiating Gouty Arthritis and Calcium Pyrophosphate Deposition Disease. Chinese Journal of Bone and Joint, 14(8): 729–733.
[30] Zheng T, Huang J, Kang C, et al., 2024, Efficacy of Musculoskeletal Ultrasound in the Differential Diagnosis of Gouty Arthritis and Calcium Pyrophosphate Deposition Disease. Heilongjiang Medicine, 37(6): 1427–1430.
[31] Huffman N, Pasqualini I, Surace P, et al., 2023, Diagnosis, Treatment, and Outcomes of Crystalline Arthropathy in the Setting of Total Knee Arthroplasty: A Critical Analysis Review. JBJS Rev, 11(12): e23.00163.
[32] Doski S, Sebastiao A, Thayaparan P, 2024, The Investigation and Management of Peri-Prosthetic Joint Infection After Total Knee Arthroplasty: An Update Based on the Latest British Orthopaedic Association Standard and Speciality Standard Guidelines. Cureus, 16(11): e73315.
[33] Alt V, Szymski D, Rupp M, et al., 2025, The Health-Economic Burden of Hip and Knee Periprosthetic Joint Infections in Europe: A Comprehensive Analysis Following Primary Arthroplasty. Bone Jt Open, 6(3): 298–311.
[34] Parvataneni HK, Gray CF, Prieto HA, et al., 2026, Clinical and Psychosocial Impact of Limited Mobility During the Interstage Period of Two-Stage Revision Arthroplasty for Prosthetic Joint Infection: A State-of-the-Art Review. J Orthop Surg Res, 21(1): 577.